Thujone, a naturally occurring
monoterpene, was found to enhance the total WBC count, bone marrow cellularity, number of α-
esterase positive cells, number of plaque forming cells in spleen and circulating antibody titer in Balb/c mice (1mg/kg
body weight, intraperitoneally for 5 days).
Thujone treatment enhanced proliferation of splenocytes and thymocytes, both in the presence and absence of specific
mitogens. Administration of
Thujone was found to stimulate the cell-mediated immunological response in normal and
tumor bearing Balb/c mice. A significant enhancement in natural killer (NK) cell mediated cytotoxicity, antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent
complement mediated cytotoxicity (ACC) in both normal as well as
tumor-bearing animals was observed after the administration of
Thujone. Production of
cytokines such as
IL-2 and IFN-γ was significantly enhanced by the administration of
Thujone. The stimulatory effect of
Thujone on cytotoxic T lymphocyte (CTL) generation was determined by Winn's neutralization assay using CTL sensitive EL4
thymoma cells.
Thujone treatment showed a significant increase in CTL production in both the in vivo and in vitro models, as indicated by a significant increase in the life span of
tumor bearing animals. All these results indicate that administration of
Thujone could enhance the immune response of mice. There was a significant reduction in solid
tumor development, mediated by the presence of alert immune responses during
Thujone administration.